Delta Lloyd NV raised its stake in shares of Cerner Corp. (NASDAQ:CERN) by 19.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 28,758 shares of the company’s stock after buying an additional 4,633 shares during the period. Delta Lloyd NV’s holdings in Cerner Corp. were worth $1,776,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of CERN. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its position in Cerner Corp. by 615.5% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 7,155 shares of the company’s stock valued at $419,000 after buying an additional 6,155 shares during the period. Webster Bank N. A. increased its position in Cerner Corp. by 9.4% in the second quarter. Webster Bank N. A. now owns 30,050 shares of the company’s stock valued at $1,761,000 after buying an additional 2,576 shares during the period. LGT Capital Partners LTD. increased its position in Cerner Corp. by 13.6% in the second quarter. LGT Capital Partners LTD. now owns 117,000 shares of the company’s stock valued at $6,856,000 after buying an additional 14,000 shares during the period. Alpha Windward LLC increased its position in Cerner Corp. by 2.2% in the second quarter. Alpha Windward LLC now owns 2,061 shares of the company’s stock valued at $121,000 after buying an additional 44 shares during the period. Finally, Chevy Chase Trust Holdings Inc. increased its position in Cerner Corp. by 0.7% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 257,447 shares of the company’s stock valued at $15,086,000 after buying an additional 1,699 shares during the period. Hedge funds and other institutional investors own 81.17% of the company’s stock.

Institutional Ownership by Quarter for Cerner Corp. (NASDAQ:CERN)

Cerner Corp. (NASDAQ:CERN) traded down 2.16% during mid-day trading on Tuesday, reaching $49.77. 5,047,159 shares of the company’s stock traded hands. The stock has a market capitalization of $16.90 billion, a PE ratio of 26.32 and a beta of 1.11. Cerner Corp. has a 12 month low of $48.04 and a 12 month high of $67.50. The firm’s 50-day moving average price is $55.06 and its 200 day moving average price is $59.05.

Cerner Corp. (NASDAQ:CERN) last released its quarterly earnings data on Tuesday, November 1st. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.60 by $0.01. Cerner Corp. had a return on equity of 18.39% and a net margin of 13.85%. The firm earned $1.19 billion during the quarter, compared to analyst estimates of $1.24 billion. During the same quarter in the prior year, the company posted $0.54 EPS. The company’s quarterly revenue was up 5.1% on a year-over-year basis. Equities research analysts predict that Cerner Corp. will post $2.30 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Delta Lloyd NV Raises Position in Cerner Corp. (CERN)” was first published by Daily Political and is the propert of of Daily Political. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of US & international copyright law. The original version of this piece of content can be read at http://www.dailypolitical.com/2016/11/29/delta-lloyd-nv-raises-position-in-cerner-corp-cern.html.

Several equities analysts have weighed in on the stock. Vetr downgraded shares of Cerner Corp. from a “hold” rating to a “sell” rating and set a $64.78 target price for the company. in a report on Monday, August 8th. Deutsche Bank AG raised their target price on shares of Cerner Corp. from $66.00 to $70.00 and gave the company a “buy” rating in a report on Monday, August 15th. JPMorgan Chase & Co. reiterated a “buy” rating on shares of Cerner Corp. in a report on Wednesday, August 3rd. Cowen and Company downgraded shares of Cerner Corp. from an “outperform” rating to a “market perform” rating and set a $65.00 price target for the company. in a report on Thursday, September 8th. Finally, Stifel Nicolaus assumed coverage on shares of Cerner Corp. in a report on Wednesday, August 31st. They set a “hold” rating for the company. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $64.88.

In related news, Director William D. Zollars sold 10,000 shares of the stock in a transaction that occurred on Monday, November 7th. The stock was sold at an average price of $51.50, for a total value of $515,000.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Linda M. Dillman sold 6,000 shares of the stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $64.68, for a total value of $388,080.00. The disclosure for this sale can be found here. 13.20% of the stock is owned by corporate insiders.

About Cerner Corp.

Cerner Corporation is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations. Its segments include Domestic and Global. The Domestic segment includes the business activity in the United States.

5 Day Chart for NASDAQ:CERN

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Corp. (NASDAQ:CERN).

Receive News & Ratings for Cerner Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corp. and related companies with MarketBeat.com's FREE daily email newsletter.